Dr. William W. Thoms Jr., MD

Dr. Thoms practices at Wellstar North Fulton Medical Center in Roswell, Georgia, part of Wellstar Health System.

Dr. Thoms' NPI, 1215087309, was assigned on January 11, 2007. Dr. Thoms graduated from Temple University School of Medicine in 1985. Dr. Thoms holds Georgia license 35343.

Dr. Thoms' primary practice is Wellstar North Fulton Medical Center, at 3000 Hospital Boulevard, Roswell, GA 30076 in Fulton County. The practice phone is (770) 751-2500.

Dr. Thoms' primary practice is Wellstar North Fulton Medical Center in Roswell, Georgia, part of Wellstar Health System. Dr. Thoms is also affiliated with Wellstar Kennestone Regional Medical Center. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Thoms to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thoms practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Thoms' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Thoms is licensed in Georgia.

CMS data shows 193 Medicare services from Dr. Thoms across 1 procedure code in 2024, for 60 Medicare patients. Medicare paid $6,852 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Thoms in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thoms' median patient age at 71, with 59% women.

In 2024, Dr. Thoms wrote 52 Medicare Part D claims for 30 patients. 100% of them were for generic drugs. CMS names the drug for 26 of them, across 1 drug with 11 or more claims each, at $261 in total drug cost. In 2023, CMS named 70 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Thoms for performance year 2024, reported through an alternative payment model (APM). Dr. Thoms accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Thoms to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 166 general payments to Dr. Thoms from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Bristol-Myers Squibb Company paid the most, $648.

Dr. Thoms graduated from Temple University School of Medicine in 1985.